Substance Use Disorder in Chemsex Practice

NCT ID: NCT06476873

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

1000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of this descriptive cross-sectional study is to assess the prevalence of chemsex substance use disorder among chemsexers via an online self-questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chemsex appeared in Europe around 2006 and in France in 2010. It involves the use of psychoactive substances in a sexual context to enhance, initiate, facilitate or prolong sexual intercourse through the psychoactive effects of the molecules consumed. These molecules are essentially synthetic cathinones, GHB/GBL, MDMA, methamphetamines, cocaine and ketamine. These products are often used in combination with erectile dysfunction treatments (side effects of the molecules). This practice is thought to affect almost 20% of MSM.

This use has numerous social, somatic, psychiatric and addictive consequences. Studies have mainly focused on infectious risks, psychiatric complications (e.g. anxiety and depression) or the prevalence of this phenomenon. However, no study has assessed the prevalence of chemsex-related substance use disorders among these users.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Addiction Chemical Use, Substance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

cohort
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Online self-questionnaire.

Descriptive, cross-sectional study This study is aimed at adult chemsex users over the last 12 months (having experimented with chemsex at least once over the last 12 months) and with a good understanding of French.

An online LimeSurvey-type self-questionnaire will be accessible via a URL link to collect and secure the data. A presentation of the study, information on chemsex and help and care services, as well as the information note will be available.

The questionnaire will be distributed via a QR code, giving direct access to the study's web page, or directly via the web link. Posters and flyers will be used in hospitals and/or private clinics, addictology centers, STI prevention and screening centers and associations, as well as via social networks, dating apps and sites, and the online and print press.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be 18 years of age or older.
* Proficiency in written French
* Have practised chemsex at least once in the last 12 months.
* Agree to participate in the study.

Exclusion Criteria

* Have not experimented with chemsex in the last 12 months
* Participation in other ongoing research
* Insufficient written comprehension of French
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Charles Perrens, Bordeaux

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Charles PERRENS

Bordeaux, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Melina FATSEAS

Role: CONTACT

05 24 54 90 00

Helen SAVARIEAU

Role: CONTACT

05 56 56 35 56

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Melina FATSEAS, MD, Prof

Role: primary

0524549000

Helen SAVARIEAU

Role: backup

0556563556

References

Explore related publications, articles, or registry entries linked to this study.

Diestelmann M, Zangl A, Herrle I, Koch E, Graw M, Paul LD. MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations. Forensic Sci Int. 2018 Feb;283:72-84. doi: 10.1016/j.forsciint.2017.12.003. Epub 2017 Dec 8.

Reference Type BACKGROUND
PMID: 29275216 (View on PubMed)

Blanc JV, Burdairon JD, Malandain L, Ferreri F, Mouchabac S, Adrien V. Attachment and Mental Health of Men Having Sex with Men Engaging in Chemsex: Is Substance Abuse Only the Tip of the Iceberg? J Homosex. 2024 Oct 14;71(12):2875-2894. doi: 10.1080/00918369.2023.2266086. Epub 2023 Oct 10.

Reference Type BACKGROUND
PMID: 37815854 (View on PubMed)

Serre A, Vuillot O, Eiden C, Gambier J, Berger A, Mathieu O, Nefau T, Sebbane M, Donnadieu-Rigole H, Peyriere H. Acute Psychiatric Disorders Related to Fake Cathinone: Ephylone. J Anal Toxicol. 2019 Aug 23;43(7):e1-e2. doi: 10.1093/jat/bkz020. No abstract available.

Reference Type BACKGROUND
PMID: 31095710 (View on PubMed)

Evers YJ, Van Liere GAFS, Hoebe CJPA, Dukers-Muijrers NHTM. Chemsex among men who have sex with men living outside major cities and associations with sexually transmitted infections: A cross-sectional study in the Netherlands. PLoS One. 2019 May 14;14(5):e0216732. doi: 10.1371/journal.pone.0216732. eCollection 2019.

Reference Type BACKGROUND
PMID: 31086390 (View on PubMed)

Gilbart VL, Simms I, Gobin M, Oliver I, Hughes G. High-risk drug practices in men who have sex with men. Lancet. 2013 Apr 20;381(9875):1358-1359. doi: 10.1016/S0140-6736(13)60882-X. No abstract available.

Reference Type BACKGROUND
PMID: 23601946 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A00737-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Age-Related Effects of THC
NCT04294966 COMPLETED EARLY_PHASE1
Behavior Brain Responses
NCT03964350 COMPLETED EARLY_PHASE1
Personality and Drug Use
NCT05516823 UNKNOWN
Behavioral Effects of Pregabalin and Cannabis
NCT01511640 COMPLETED EARLY_PHASE1
Dose-response of Cannabis and Driving
NCT03656029 COMPLETED PHASE2